Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neolpharma Group is a private Mexican pharmaceutical group focused on the research, development, manufacturing, commercialization, and distribution of medicines, with a strong emphasis on generic and branded-generic products. The company operates multiple manufacturing assets, including its Vallejo site in Mexico City, a Puerto Rico production facility, and NeolSyM, a multipurpose plant dedicated to active pharmaceutical ingredients. Its portfolio includes nearly 200 registered products and more than 300 dosage forms spanning CNS, oncology, cardiovascular, anti-infective, endocrine, gastrointestinal, pulmonary, rheumatology, gynecology, and OTC categories. Beyond finished-dose products, the group offers manufacturing, packaging, warehousing, distribution, QA, technology-transfer, stability, and pharmacovigilance-related services. Overall, Neolpharma appears to be a vertically integrated commercial pharmaceutical manufacturer rather than a venture-stage biotech with a discrete clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neolpharma Group.